(Q36709158)

15 August 2017

1 reference

title

Pulmonary complications of common variable immunodeficiency (English)

1 reference

Charlotte Cunningham-Rundles

15 August 2017

author

series ordinal

3

object named as

Charlotte Cunningham-Rundles

1 reference

15 August 2017

Paula J Busse

1

1 reference

15 August 2017

Sherry Farzan

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Annals of Allergy, Asthma & Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

98

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

1-8; quiz 8-11, 43

1 reference

Common variable immunodeficiency: clinical and immunological features of 248 patients.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Respiratory disorders in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

A preliminary assessment of alpha-1 antitrypsin S and Z deficiency allele frequencies in common variable immunodeficiency patients with and without bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Pulmonary abnormalities in patients with primary hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Pseudomonas aeruginosa adherence to human basement membrane collagen in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Bronchial inflammation and colonization in patients with clinically stable bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Relationships between high-resolution computed tomography, lung function and bacteriology in stable bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Immediate hypersensitivity in adults with IgG deficiency and recurrent respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Chronic urticaria and angioedema as the first presentations of common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Pulmonary complications of primary immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Diffuse Pulmonary Lymphoreticular Infiltrations Associated with Dysproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Coexistent Lymphoid Interstitial Pneumonia, Pernicious Anemia, and Agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: different lymphocyte populations with a similar response to prednisone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Lymphoid interstitial pneumonia: clinical features, associations and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Hypogammaglobulinemia resembling BOOP

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Usual interstitial pneumonitis in a patient with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Granulomatous disease in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Granulomatous disease in common variable immunodeficiency: effect on immunoglobulin replacement therapy and response to steroids and splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-alpha receptor fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Etanercept treatment of cutaneous granulomas in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Incidence of cancer in 98 patients with common varied immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Characterization of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Persistence of Nontypeable Haemophilus influenzae in Adenoid Macrophages: A Putative Colonization Mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Impact of IgG replacement therapy and antibiotic treatment on the colonization of non-encapsulated Haemophilus influenzae in the nasopharynx in patients with hypogammaglobulinaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Chronic lung damage caused by adenovirus type 7: a ten-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Immunoglobulin replacement therapy by slow subcutaneous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Clinical utility of high-resolution pulmonary computed tomography in children with antibody deficiency disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960853-8

7 January 2021

10.1016/S1081-1206(10)60853-8

Identifiers

DOI

1 reference

15 August 2017

1 reference